Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases

Xiying Shang1, Xinjian Lin, Edwin Alvarez

  • 1Department of Medicine and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.

Neoplasia (New York, N.Y.)
|October 26, 2012
PubMed

Insights

Claudin-3 and claudin-4 proteins are crucial for ovarian cancer. Their reduced expression accelerates tumor growth and metastasis by affecting E-cadherin and beta-catenin signaling pathways.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Metastasis

Background:

  • Tight junction (TJ) formation regulates cancer cell motility, invasion, and metastasis.
  • Claudins are essential proteins for TJ formation and maintenance.
  • Claudin-3 (CLDN3) and claudin-4 (CLDN4) are highly expressed in most ovarian cancers.

Purpose of the Study:

  • To investigate the role of CLDN3 and CLDN4 in constraining ovarian cancer xenograft growth and limiting metastatic potential.
  • To elucidate the molecular mechanisms by which CLDN3 and CLDN4 influence cancer progression.

Main Methods:

  • Gene knockdown of CLDN3 and CLDN4 in human 2008 cancer xenografts.
  • In vivo growth rate and metastatic potential assessment.
  • Analysis of cell proliferation (Ki67) and apoptosis (TUNEL).
  • Measurement of transepithelial electrical resistance and paracellular flux.
  • In vitro migration and invasion assays.
  • Western blotting and RT-PCR for E-cadherin, GSK-3β, and β-catenin pathway components.

Main Results:

  • CLDN3 and CLDN4 knockdown significantly increased in vivo tumor growth rate (2.3-fold and 3.7-fold, respectively) without affecting in vitro growth.
  • Knockdown led to increased cell proliferation and decreased apoptosis in xenografts.
  • Reduced TJ integrity, enhanced cell migration and invasion, and increased lung colonization were observed upon claudin knockdown.
  • Loss of CLDN3/CLDN4 resulted in decreased E-cadherin expression and activation of the β-catenin signaling pathway.
  • Knockdown of CLDN3 and CLDN4 increased lung metastatic burden by 1.7-fold and 2.4-fold, respectively.

Conclusions:

  • CLDN3 and CLDN4 constrain ovarian cancer growth and metastasis in vivo.
  • These claudins maintain E-cadherin expression and limit β-catenin pathway activation, thereby restricting tumor progression.
  • Targeting CLDN3 and CLDN4 may offer therapeutic strategies for ovarian cancer treatment.

Related Concept Videos

Tight Junctions01:29

Tight Junctions

Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...